Can-Fite BioPharma Ltd. (CANF): key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2025)
- $405.0K
- Net Income/Loss (FY2025)
- -$9.8M
- Total Assets (FY2025)
- $9.5M
- Total Equity (FY2025)
- $5.6M
- Cash Flows from Operating Activities (FY2025)
- -$8.9M
Source: Can-Fite BioPharma Ltd. 20-F filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
